Fagron N.V.
General ticker "ARSUF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.6B (TTM average)
Fagron N.V. follows the US Stock Market performance with the rate: 36.0%.
Estimated limits based on current volatility of 0.0%: low 23.50$, high 23.50$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-20, amount 0.39$ (Y1.66%)
Short-term ARSUF quotes
Long-term ARSUF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €683.88MM | €762.99MM | €871.96MM |
| Operating Expenses | €585.97MM | €654.36MM | €741.26MM |
| Operating Income | €97.91MM | €108.63MM | €130.70MM |
| Non-Operating Income | €-10.14MM | €-24.19MM | €-26.40MM |
| Interest Expense | €10.62MM | €22.98MM | €26.57MM |
| R&D Expense | €2.30MM | €2.70MM | €0.00MM |
| Income(Loss) | €87.77MM | €84.44MM | €104.30MM |
| Taxes | €17.70MM | €13.40MM | €23.30MM |
| Profit(Loss)* | €69.61MM | €70.55MM | €80.55MM |
| Stockholders Equity | €402.65MM | €463.75MM | €501.35MM |
| Inventory | €108.34MM | €113.94MM | €136.96MM |
| Assets | €971.01MM | €1,006.95MM | €1,083.52MM |
| Operating Cash Flow | €109.46MM | €124.63MM | €109.89MM |
| Capital expenditure | €18.50MM | €38.47MM | €40.80MM |
| Investing Cash Flow | €-69.27MM | €-44.76MM | €-69.74MM |
| Financing Cash Flow | €13.85MM | €-74.28MM | €-54.01MM |
| Earnings Per Share** | €0.96 | €0.97 | €1.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.